<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000728322"><TermName>CeeNU</TermName><TermDefinition><DefinitionText>A drug used to treat brain tumors that have already been treated with surgery or radiation therapy. It is also used to treat Hodgkin lymphoma that has not gotten better with other types of treatment or has come back. It is being studied in the treatment of other types of cancer. CeeNU damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent. Also called CCNU and lomustine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000737325" type="audio/mpeg" alt="Pronunciation of dictionary&#10;         term &quot;CeeNU&quot;" language="en" id="_3"/><SpanishTermName>CeeNU</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para el tratamiento de los  tumores cerebrales que han sido sometidos a  cirugía o radioterapia. También se usa en los casos de un linfoma de Hodgkin que no mejoró con otros tipos de tratamiento o que regresó. Está en estudio para el tratamiento de otros tipos de cáncer. CeeNU daña el ADN de las células y podría destruir células cancerosas. Es un tipo de alquilante. También se llama CCNU y lomustina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2012-06-14</DateFirstPublished><DateLastModified>2012-06-14</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000725247">Lomustine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
